SCHEMBL5086322

SCHEMBL5086322

CCC(O)c1nc(N)nc(N)c1-c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 7/20 0.58
HEXA P06865 5/20 0.58
HEXB P07686 5/20 0.58
LMNA P02545 2/20 0.42
MEN1 O00255 1/20 0.41
SLC22A1 O15245 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
HTR2A P28223 1/20 0.41
ADRA1A P35348 1/20 0.41
HTR2B P41595 1/20 0.41
SLC6A3 Q01959 1/20 0.41
KMT2A Q03164 1/20 0.41
PDE4D Q08499 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5086312 0.77 RECQL (0.49) DHFRHEXAHEXBLMNAALDH1A1
SCHEMBL7162150 0.75 DHFR (0.66) DHFRHEXAHEXBLMNAALDH1A1
SCHEMBL3498787 0.73 HEXA (1.00) DHFRHEXAHEXBLMNAMEN1
SCHEMBL3502224 0.71 DHFR (0.78) DHFRHEXAHEXBLMNAMEN1
SCHEMBL3500167 0.71 DHFR (0.61) DHFRHEXAHEXBLMNAALDH1A1
SCHEMBL1031028 0.71 DHFR (0.56) DHFRHEXAHEXBLMNAALDH1A1
SCHEMBL28594009 0.70 DHFR (0.56) DHFRHEXAHEXBALDH1A1TDP1
SCHEMBL11818733 0.69 HEXA (0.55) DHFRHEXAHEXBLMNAMEN1
SCHEMBL2473930 0.69 DHFR (0.58) DHFRHEXAHEXBLMNAALDH1A1
Hydrochloric Acid SCHEMBL11822636 0.68 HEXA (0.54) DHFRHEXAHEXBLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904457-A2 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY Rigel Pharmaceuticals, Inc. (US) 2008-04-02 EP claimed
WO-2006133426-A2 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY RIGEL PHARMACEUTICALS, INC. (US) 2006-12-14 WO claimed